Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10072-020-04519-x http://scihub22266oqcxt.onion/10.1007/s10072-020-04519-x 32617741!7331489!32617741     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Neurol+Sci 2020 ; 41 (7): 1647-1650 Nephropedia Template TP {{tp|p=32617741|t=2020. Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study |pdf=|usr=}}{{32617741}} gab.com Text Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study JO: Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32617741 #FOAvip We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic. Twit Text FOAVip Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study ????Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32617741 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32617741 #FOAvip English Wikipedia <ref>{{Cite pmid|32617741}}</ref> Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study #MMPMID32617741 Dalla Costa G; Leocani L; Montalban X; Guerrero AI; Sorensen PS; Magyari M; Dobson RJB; Cummins N; Narayan VA; Hotopf M; Comi G Neurol Sci 2020[Jul]; 41 (7): 1647-1650 PMID32617741show ga We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic. |*Betacoronavirus[MESH] |Adult[MESH] |Alemtuzumab/therapeutic use[MESH] |COVID-19[MESH] |Coronavirus Infections/drug therapy/*epidemiology[MESH] |Europe[MESH] |Female[MESH] |Humans[MESH] |Longitudinal Studies[MESH] |Male[MESH] |Middle Aged[MESH] |Multiple Sclerosis/complications/*epidemiology/*virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/drug therapy/*epidemiology[MESH] |Prevalence[MESH]Real-time assessment of COVID-19 prevalence among multiple sclerosis p(epmc).pdf DeepDyve Pubget Overpricing